???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Bibiana Ferreira

Nomes de citação

  • Ferreira, Bibiana I.

Identificadores de autor

Ciência ID
A311-E925-09C5
ORCID iD
0000-0003-4772-9395

Endereços de correio eletrónico

  • bibiana.i.ferreira@gmail.com (Pessoal)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica
  • Ciências Naturais - Ciências Biológicas - Biologia Celular
  • Ciências Naturais - Ciências Biológicas - Biologia Molecular
  • Ciências Médicas e da Saúde - Medicina Clínica - Oncologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Espanhol; Castelhano Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C1) Utilizador proficiente (C2) Utilizador proficiente (C2)
Português (Idioma materno)
Formação
Grau Classificação
2009/11/26
Concluído
Biologia molecular, Bioquímica y Biomedicina (Doctor)
Universidad Autónoma de Madrid, Espanha

Centro Nacional de Investigaciones Oncológicas, Espanha
"ROLE OF GENOMIC INSTABILITY WITHIN THE CONTEXT OF CHROMOSOMAL REARRANGEMENTS" (TESE/DISSERTAÇÃO)
Summa Cum Laude
2005/06/16
Concluído
Biologia (Licenciatura)
Universidade de Aveiro, Portugal
Produções

Publicações

Artigo em revista
  1. Ferreira, Bibiana I.; Link, Wolfgang. "Small molecule inhibitors of CRM1". Frontiers in Pharmacology (2020):
    Aceite para publicação • 10.3389/FPHAR.2020.00625
  2. Jacinto, Filipe V.; Link, Wolfgang; Ferreira, Bibiana I.. "CRISPR/Cas9-mediated genome editing: From basic research to translational medicine". Journal of Cellular and Molecular Medicine (2020): http://dx.doi.org/10.1111/jcmm.14916.
    No prelo • 10.1111/jcmm.14916
  3. Ferreira, Bibiana I.. "Connectivity Map-based discovery of Harmine to overcome TRIB2-mediated therapy resistance". Oncogene (2020):
    Submetido
  4. Henriques, Vanessa; Martins, Teresa; Link, Wolfgang; Ferreira, Bibiana I.. "The Emerging Therapeutic Landscape of Advanced Melanoma". Current Pharmaceutical Design 24 5 (2018): 549-558. http://dx.doi.org/10.2174/1381612824666180125093357.
    Publicado • 10.2174/1381612824666180125093357
  5. Hill, Richard; Madureira, Patricia A.; Ferreira, Bibiana; Baptista, Inês; Machado, Susana; Colaço, Laura; dos Santos, Marta; et al. "TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT". Nature Communications 8 1 (2017): http://dx.doi.org/10.1038/ncomms14687.
    Publicado • 10.1038/ncomms14687
  6. Ferreira, Bibiana I.; Lie, Maria K.; Engelsen, Agnete S. T.; Machado, Susana; Link, Wolfgang; Lorens, James B.. "Adaptive mechanisms of resistance to anti-neoplastic agents". MedChemComm 8 1 (2017): 53-66. http://dx.doi.org/10.1039/c6md00394j.
    10.1039/c6md00394j
  7. Cautain, Bastien; Castillo, Francisco; Musso, Loana; Ferreira, Bibiana I.; de Pedro, Nuria; Rodriguez Quesada, Lorena; Machado, Susana; et al. "Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling". PLOS ONE 11 12 (2016): e0167491. http://dx.doi.org/10.1371/journal.pone.0167491.
    10.1371/journal.pone.0167491
  8. Ferreira, Bibiana I.. "Subcellular Protein Localisation in Health and Disease". eLS (2016):
    Publicado
  9. Ferreira, Bibiana I.; Hill, Richard; Link, Wolfgang. "Special Review: Caught in the Crosshairs: Targeted Drugs and Personalized Medicine.". The Cancer Journal 21 6 (2015): 441-447. http://dx.doi.org/10.1097/ppo.0000000000000161.
    10.1097/ppo.0000000000000161
  10. Rio-Machin, A; Ferreira, B I; Henry, T; Gómez-López, G; Agirre, X; Alvarez, S; Rodriguez-Perales, S; et al. "Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype". Leukemia 27 4 (2012): 925-931. http://dx.doi.org/10.1038/leu.2012.302.
    10.1038/leu.2012.302
  11. Rio-Machin, A.; Menezes, J.; Maiques-Diaz, A.; Agirre, X.; Ferreira, B. I.; Acquadro, F.; Rodriguez-Perales, S.; et al. "Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22)". Haematologica 97 4 (2011): 534-537. http://dx.doi.org/10.3324/haematol.2011.050567.
    10.3324/haematol.2011.050567
  12. Sánchez-Schmidt, Júlia Ma; Salgado, Rocío; Servitje, Octavio; Gallardo, Fernando; Ortiz-Romero, Pablo L.; Karpova, Maria B.; Zipser, Marie C.; et al. "Primary Cutaneous CD30+ Anaplastic Large-Cell Lymphomas Show a Heterogeneous Genomic Profile: An Oligonucleotide ArrayCGH Approach". Journal of Investigative Dermatology 131 1 (2011): 269-271. http://dx.doi.org/10.1038/jid.2010.271.
    10.1038/jid.2010.271
  13. Di Lisio, L; Gómez-López, G; Sánchez-Beato, M; Gómez-Abad, C; Rodríguez, M E; Villuendas, R; Ferreira, B I; et al. "Mantle cell lymphoma: transcriptional regulation by microRNAs". Leukemia 24 7 (2010): 1335-1342. http://dx.doi.org/10.1038/leu.2010.91.
    10.1038/leu.2010.91
  14. Salgado, Rocío; Servitje, Octavio; Gallardo, Fernando; Vermeer, Maarten H.; Ortiz-Romero, Pablo L.; Karpova, Maria B.; Zipser, Marie C.; et al. "Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides". Journal of Investigative Dermatology 130 4 (2010): 1126-1135. http://dx.doi.org/10.1038/jid.2009.306.
    10.1038/jid.2009.306
  15. Marcos, Nuno T.; Magalhães, Ana; Ferreira, Bibiana; Oliveira, Maria J.; Carvalho, Ana S.; Mendes, Nuno; Gilmartin, Tim; et al. "Helicobacter pylori induces ß3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl–Lewis x". Journal of Clinical Investigation (2008): http://dx.doi.org/10.1172/jci34324.
    10.1172/jci34324
  16. Ferreira, B. I.; Garcia, J. F.; Suela, J.; Mollejo, M.; Camacho, F. I.; Carro, A.; Montes, S.; Piris, M. A.; Cigudosa, J. C.. "Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia". Haematologica 93 5 (2008): 670-679. http://dx.doi.org/10.3324/haematol.12221.
    10.3324/haematol.12221
  17. Ferreira, B I; Alonso, J; Carrillo, J; Acquadro, F; Largo, C; Suela, J; Teixeira, M R; et al. "Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma". Oncogene 27 14 (2007): 2084-2090. http://dx.doi.org/10.1038/sj.onc.1210845.
    10.1038/sj.onc.1210845
  18. Largo, C.; Saez, B.; Alvarez, S.; Suela, J.; Ferreira, B.; Blesa, D.; Prosper, F.; Calasanz, M. J.; Cigudosa, J. C.. "Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations". Haematologica 92 6 (2007): 795-802. http://dx.doi.org/10.3324/haematol.11052.
    10.3324/haematol.11052
  19. Pinho, Sandra; Marcos, Nuno T.; Ferreira, Bibiana; Carvalho, Ana S.; Oliveira, Maria J.; Santos-Silva, Filipe; Harduin-Lepers, Anne; Reis, Celso A.. "Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cells". Cancer Letters 249 2 (2007): 157-170. http://dx.doi.org/10.1016/j.canlet.2006.08.010.
    10.1016/j.canlet.2006.08.010
  20. Suela, J; Álvarez, S; Cifuentes, F; Largo, C; Ferreira, B I; Blesa, D; Ardanaz, M; et al. "DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups". Leukemia 21 6 (2007): 1224-1231. http://dx.doi.org/10.1038/sj.leu.2404653.
    10.1038/sj.leu.2404653
  21. Suela, Javier; Largo, Cristina; Ferreira, Bibiana; Álvarez, Sara; Robledo, Mercedes; González-Neira, Anna; Calasanz, Maria José; Cigudosa, Juan C.. "Neurofibromatosis 1, and Not TP53, Seems to Be the Main Target of Chromosome 17 Deletions in De Novo Acute Myeloid Leukemia". Journal of Clinical Oncology 25 9 (2007): 1151-1152. http://dx.doi.org/10.1200/jco.2006.09.3013.
    10.1200/jco.2006.09.3013